ClinicalTrials.gg
Enrolling by invitationNCT06486493Updated Oct 30, 2026

Impact of a Playful Family Education Strategy With ICT on Childhood Obesity Prevention

An interventional study of Playful Family Education Strategy in Pediatric Obesity, Childhood Obesity and Childhood Overweight, sponsored by Instituto Mexicano del Seguro Social. Enrolling by invitation at 1 site in Mexico. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Instituto Mexicano del Seguro Social · Not applicable, Interventional, and Prevention

How we know

Updated Oct 30, 2026Now Enrolling by invitationStart date moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Not applicable
Ages
6 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 22 studies in Pediatric Obesity with a site in Mexico — 3 open to participants now, 3 under way, none of them phase 3. Pediatric Obesity · Mexico.

Planned enrollment
5th of 20
200 · median 112
Started
2025
with 1 other
No phase
19 of 22
3 open now
Registered
20th of 22
by date
Lead sponsor
1 of 22
Instituto Mexicano del Seguro Social

Among the 22 studies in Pediatric Obesity with a site in Mexico, this one is the 5th largest by planned enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2025, is one of 19 with no phase, and was the 20th registered.

Pediatric Obesity

1,132 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.

Browse Pediatric Obesity studies →

Open to participants now

3 of the 22 studies in Pediatric Obesity with a site in Mexico are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Mexico have not opened yet or have stopped. Only those recruiting at a site in Mexico →

Who these studies take

Of the 119 Pediatric Obesity studies recruiting now, 16 (13%) set no upper age limit and 101 (85%) stop at 75 or younger; 110 take children under 18; 67 take healthy volunteers.

This study: 6 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Pediatric Obesity with a site in Mexico, or all of them as a file.
02

Study summary

The goal of this non-randomized quasi experimental clinical controlled trial is to evaluate the impact of a playful family education strategy reinforced by the use of communication technologies in childhood obesity. The main questions to answer are:

  • Does a technogical reinforced ludical family strategy might reduce overweight and childhood obesity prevalence and incidence reduction?
  • Can digital reinforcement might decrease body weight, BMI, body fat mass and waist circumference in overweight or obese children?
  • Does dietary habits might be improved by a technologically reinforced playful family workshop?

Researchers will evaluate the effect of a family-based, playful educational strategy, incorporating digital reinforcement, aimed at promoting healthy lifestyles among school-aged children, with the goal of reducing and preventing childhood obesity.

Read the detailed description

Obesity, in both adults and children, is a major global health issue due to its associated morbidity and mortality. According to the latest report from the World Obesity Federation (WOF), Mexico ranks eighth in childhood obesity. Furthermore, the 2020-2024 National Health and Nutrition Survey (ENSANUT) indicates that at least 4 out of every 10 Mexican school-aged children or adolescents are overweight or obese.

Although its origins are multifactorial, poor lifestyle choices are a primary driver of the condition. This is a consequence of shifts in dietary patterns and an "obesogenic" environment, characterized by the excessive consumption of ultra-processed products and a sedentary lifestyle, which directly impacts health from an early age.

In this context, the WHO guidelines on the integrated management of childhood obesity identify behavioral interventions as a cornerstone of care, whether through educational strategies, technology-based approaches, nutritional programs, or physical activity. However, the current level of evidence supporting these interventions remains very low.

Consequently, a family-oriented, play-based educational strategy, supported by digital tools, has been developed. This approach encourages the active participation of children, parents, and teachers within the school environment, with the goal of reducing the prevalence and incidence of childhood overweight and obesity by promoting healthy lifestyles.

To this end, 200 schoolchildren (aged 6 to 12) and their families will participate in educational workshops and receive digital reinforcement over a six-month period. This workshop is based on national and international guidelines for managing overweight and obesity in school-aged children, developed by the Food and Agriculture Organization of the United Nations (FAO). It is also aligned with the content of the "Nueva Escuela Mexicana" framework established by the Secretaría de Educación Pública (SEP).

The primary outcome is a change in the baseline body mass index (BMI) z-score. Secondary objectives include changes in other anthropometric variables, such as weight, waist circumference, and fat mass-as well as blood pressure and fasting clinical chemistry parameters (glucose, insulin, triglycerides, total cholesterol, LDL cholesterol, HDL cholesterol, AST, and ALT). Furthermore, changes in behavioral patterns are expected, specifically improvements in dietary habits, which will be assessed using a food frequency questionnaire (FFQ) and a 24-hour dietary recall.

03

Conditions studied

  • Pediatric Obesity
  • Childhood Obesity
  • Childhood Overweight

Browse trials for

Keywords

  • Pediatric Obesity
  • Childhood Obesity
  • Educational Activities
  • Technology
  • Gamification
04

Who can participate

The criteria were revised on the registry on Oct 30, 2026. See what changed

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • School-aged children (6 to 12 years old) enrolled in primary schools located in Mexico City, Mexico.
  • Children accompanied by their parents, who provide consent for their participation in the study.
  • Children who have agreed to participate by signing and assent documents.

Exclusion criteria

Exclusion Criteria:

  • Children undergoing in any type of weight reduction program, whether pharmacological or non-pharmacological treatment .
  • Children with a prior diagnosis of endocrinological or congenital diseases, associated with obesity, such as hypothyroidism, Prader-Willi syndrome, growth hormone deficiency, Cushing's syndrome, trisomy 21, among others.
  • Children with abnormal thyroid function test results.
  • Children with physical limitations, such as congenital malformations, that may prevent them from engaging in moderate to intense physical activity included in the intervention.
  • Participants enrolled in another research protocol of any kind.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Intervention

    Behavioral: Playful Family Education Strategy

Interventions

  • BehavioralPlayful Family Education Strategy

    The program consists of in-person monthly sessions held over six months, involving the children, their parents or guardians, and their teachers. Conducted within the classroom setting. It covers six main topics: 1. Child growth and development. 2. Identifying the issue of childhood obesity. 3. Healthy eating. 4. Identifying ultra-processed products. 5. Physical activity for school-aged children. 6. Exercise for school-aged children. Digital reinforcement is provided between sessions under the supervision of a specialized medical team, through 18 digital resources, specifically, 12 videos and 6 video games that correspond to the workshop topics.

06

What researchers measure

Primary outcomes

  1. BMI Z score

    The assessment will be conducted using body weight and height (measured with a stadiometer with a precision of 0.1 cm; a weighing and measuring station with a Frankfort plane, model SECA 284), following standardized international procedures. Based on these data, the BMI (kg/m²) will be calculated, and children will be classified according to their BMI percentile, using WHO and CDC growth charts. The researchers anticipate a 5% reduction in the BMI Z-score, which is considered clinically significant.

    Time frame: Baseline and at approximately 6 months after baseline (end of intervention).

Secondary outcomes

  1. Body weight

    It will be measured using a Seca scale with an accuracy of 0.1 kg, following standardized international procedures. According to previous studies, investigators anticipate a body weight baseline reduction, at the end of intervention.

    Time frame: Baseline and at approximately 6 months after baseline (end of intervention).

  2. Body composition

    It will be assessed by bioimpedance with the Segmental Quantum V by RJL Systems body composition analyzer. After intervention investigators expect a modification of body compositon, characterized by the diminishment of body fat mass percentage at the end of intervention.

    Time frame: Baseline and at approximately 6 months after baseline (end of intervention).

  3. Waist circumference

    Measured with a Seca 201 Ergonomic Waist Circumference Measuring Tape, collocated around the stand up children body between the middle point of the anterior superior iliac spine and the costal margin, after breathing out. They will be classified according to the Third National Health and Nutrition Examination Survey (NHANES III) waist circumference tables for Mexican American children, and a percentile above 90 will be considered as an elevated risk. Investigators anticipate a reduction of waist circumference at the end of intervention in the interventional and reinforced groups.

    Time frame: Baseline and at approximately 6 months after baseline (end of intervention).

  4. Dietary habits

    It will be assessed by a 24 hour Food Frequency Questionnaire (FFQ) to capture children's usual food and drinks consumption by querying the frequency at which a predefined food list items are consumed, including portion sizes, nutrient intake (calories, fats, proteins, carbohydrates, vitamins and minerals), eating patterns (timing, frequency, and types of meals or snacks), food diversity and diet quality. Investigators anticipate a reduction of consumed carbohydrates, sweetened beverages, calorie and fat intake at the end of intervention. Accompanied by an improvement of eating patterns, food diversity and diet quality according to dietary guidelines.

    Time frame: Baseline and at approximately 6 months after baseline (end of intervention).

  5. Biochemical profile

    Determined after an 8- to 10-hour fast, consisting of glucose, insulin, triglycerides, total cholesterol, LDL cholesterol, HDL cholesterol, AST, and ALT. An improvement in the cardiometabolic profile is expected by the end of the study.

    Time frame: Baseline and at approximately 6 months after baseline (end of intervention).

07

Study locations

1 site
  • Unidad de Investigación Médica en Bioquímica, Unidad Médica de Alta Especialidad "Dr. Bernardo Sepúlveda", Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social
    Mexico City, Cuauhtémoc 06720, Mexico
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Dec 2028, 39 months after the start.

Of 542 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 39 months is above that.

Counting every sponsor, half of 544 studies reached it within 25 months; a quarter within 11 and three quarters within 45.

Start moved once since we started tracking on Sep 25, 2026: Jan 2025 → Sep 2025, on Oct 30, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2024
First posted
Jul 3, 2024
StartActual
Sep 1, 2025was Jan 2025
Primary completionEst.
Dec 2028
CompletionEst.
Dec 2029
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Enrolling by invitation
changed Oct 30, 2026
Start date
Jan 2025→Sep 1, 2025 (actual)
Oct 30, 2026
Enrollment
196→200
Oct 30, 2026
Eligibility
Minimum age 9 Years→6 Years; 3 inclusion criteria edited, 3 removed
What changed in the criteria
Inclusion criteria
  • ChangedBefore School-age children aged 9 to 12 years from the Family Medicine Unit Number 23 (IMSS, Mexico City) and the Family Medicine Units Number 1 and 3 (IMSS, Morelos).Now School-aged children (6 to 12 years old) enrolled in primary schools located in Mexico City, Mexico.
  • EditedChildren accompanied by their parents, who provide consent to participatefor their participation in the study.
  • RemovedChildren with a BMI equal to or greater than the 85th percentile (indicating overweight or obesity) according to CDC classification.
  • EditedChildren who have agreed to participate throughby signing informed consent and assent formsdocuments.
  • RemovedFamilies with access to Wi-Fi connection or mobile internet.
  • RemovedChildren with digital device (Smartphone or Tablet) access, supervised by their parents.
Oct 30, 2026
Interventions
Added Behavioral: Playful Family Education Strategy; removed Conventional treatment·Playful Family Education Strategy·Reinforced Playful Family Education Strategy. Arms added: Intervention; arms removed: Overweight conventional treatment group·Overweight workshop group·Obesity conventional treatment group·Obesity reinforcement group
Oct 30, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Reduction of childhood obesity incidence and prevalenceNow BMI Z scoreTime frame: Baseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention. → Baseline and at approximately 6 months after baseline (end of intervention).
Oct 30, 2026
Secondary outcomes
3 time frame changed, 2 added, 2 removed, 1 description edited
What changed in the outcomes
  • AddedBody compositionTime frame: Baseline and at approximately 6 months after baseline (end of intervention).
  • AddedBiochemical profileTime frame: Baseline and at approximately 6 months after baseline (end of intervention).
  • RemovedBody Mass Index (BMI)Time frame: Baseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention.
  • RemovedFat MassTime frame: Baseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention.
  • Time frameBody weightBaseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention. → Baseline and at approximately 6 months after baseline (end of intervention).
  • Time frameWaist circumferenceBaseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention. → Baseline and at approximately 6 months after baseline (end of intervention).
  • Time frameDietary habitsBaseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention. → Baseline and at approximately 6 months after baseline (end of intervention).
  • DescriptionBody weight: how it is measured was reworded
Oct 30, 2026
Contact
No study contact listed any more: removed d•••@gmail.com · •••8563; removed m•••@gmail.com · •••1093
Oct 30, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Unidad de Investigación Médica en Bioquímica, Unidad Médica de Alta Especialidad "Dr. Bernardo Sepúlveda", Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social · Mexico City, MexicoContact removed d•••@gmail.com · •••8563Contact removed m•••@gmail.com · •••1093Contact removed (no phone or email listed)Contact removed (no phone or email listed)Contact removed (no phone or email listed)
Oct 30, 2026
Sponsor
Collaborators added: Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México·Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México·Hospital General de México Dr. Eduardo Liceaga·Unidad de Vinculación de la Facultad de Medicina, UNAM en el INMEGEN·División de Educación permanente en Salud, IMSS·and 4 more
All 9

Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México · Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México · Hospital General de México Dr. Eduardo Liceaga · Unidad de Vinculación de la Facultad de Medicina, UNAM en el INMEGEN · División de Educación permanente en Salud, IMSS · Coordinación de Educación en Salud, IMSS · Programas Médicos del Área de Tamiz Metabólico Neonatal y Control del Niño Sano, IMSS · Dirección de Investigación en la Comisión Nacional de Arbitraje Médico (CONAMED) · Coordinación de Investigación en Salud, IMSS

; collaborators removed: Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México·Facultad de Medicina, Universidad Nacional Autónoma de México·Instituto Nacional de Salud Pública
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    Not yet recruiting→Enrolling by invitation
    Start date Jan 2025→Sep 1, 2025 (now actual)
    Enrollment 196→200
    Eligibility Minimum age 9 Years→6 Years; 3 inclusion criteria edited, 3 removed
    What changed in the criteria
    Inclusion criteria
    • ChangedBefore School-age children aged 9 to 12 years from the Family Medicine Unit Number 23 (IMSS, Mexico City) and the Family Medicine Units Number 1 and 3 (IMSS, Morelos).Now School-aged children (6 to 12 years old) enrolled in primary schools located in Mexico City, Mexico.
    • EditedChildren accompanied by their parents, who provide consent to participatefor their participation in the study.
    • RemovedChildren with a BMI equal to or greater than the 85th percentile (indicating overweight or obesity) according to CDC classification.
    • EditedChildren who have agreed to participate throughby signing informed consent and assent formsdocuments.
    • RemovedFamilies with access to Wi-Fi connection or mobile internet.
    • RemovedChildren with digital device (Smartphone or Tablet) access, supervised by their parents.
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Reduction of childhood obesity incidence and prevalenceNow BMI Z scoreTime frame: Baseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention. → Baseline and at approximately 6 months after baseline (end of intervention).
    Secondary outcomes 3 time frame changed, 2 added, 2 removed, 1 description edited
    What changed in the outcomes
    • AddedBody compositionTime frame: Baseline and at approximately 6 months after baseline (end of intervention).
    • AddedBiochemical profileTime frame: Baseline and at approximately 6 months after baseline (end of intervention).
    • RemovedBody Mass Index (BMI)Time frame: Baseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention.
    • RemovedFat MassTime frame: Baseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention.
    • Time frameBody weightBaseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention. → Baseline and at approximately 6 months after baseline (end of intervention).
    • Time frameWaist circumferenceBaseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention. → Baseline and at approximately 6 months after baseline (end of intervention).
    • Time frameDietary habitsBaseline, 3-month and 6-month evaluation from the start of intervention, and subsequently, at 6, 12 and 18 months post-intervention. → Baseline and at approximately 6 months after baseline (end of intervention).
    • DescriptionBody weight: how it is measured was reworded
    Interventions Added Behavioral: Playful Family Education Strategy; removed Conventional treatment·Playful Family Education Strategy·Reinforced Playful Family Education Strategy. Arms added: Intervention; arms removed: Overweight conventional treatment group·Overweight workshop group·Obesity conventional treatment group·Obesity reinforcement group
    Sponsor Collaborators added: Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México·Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México·Hospital General de México Dr. Eduardo Liceaga·Unidad de Vinculación de la Facultad de Medicina, UNAM en el INMEGEN·División de Educación permanente en Salud, IMSS·and 4 more
    All 9

    Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México · Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México · Hospital General de México Dr. Eduardo Liceaga · Unidad de Vinculación de la Facultad de Medicina, UNAM en el INMEGEN · División de Educación permanente en Salud, IMSS · Coordinación de Educación en Salud, IMSS · Programas Médicos del Área de Tamiz Metabólico Neonatal y Control del Niño Sano, IMSS · Dirección de Investigación en la Comisión Nacional de Arbitraje Médico (CONAMED) · Coordinación de Investigación en Salud, IMSS

    ; collaborators removed: Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México·Facultad de Medicina, Universidad Nacional Autónoma de México·Instituto Nacional de Salud Pública
    Contact No study contact listed any more: removed d•••@gmail.com · •••8563; removed m•••@gmail.com · •••1093
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Unidad de Investigación Médica en Bioquímica, Unidad Médica de Alta Especialidad "Dr. Bernardo Sepúlveda", Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social · Mexico City, MexicoContact removed d•••@gmail.com · •••8563Contact removed m•••@gmail.com · •••1093Contact removed (no phone or email listed)Contact removed (no phone or email listed)Contact removed (no phone or email listed)
    + 5 other changes: index terms, verification date, description, conditions and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06486493
Collaborators
Escuela Superior de Medicina, Instituto Politécnico Nacional, Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México, Hospital General de México Dr. Eduardo Liceaga, Unidad de Vinculación de la Facultad de Medicina, UNAM en el INMEGEN, División de Educación permanente en Salud, IMSS, Coordinación de Educación en Salud, IMSS, Programas Médicos del Área de Tamiz Metabólico Neonatal y Control del Niño Sano, IMSS, Dirección de Investigación en la Comisión Nacional de Arbitraje Médico (CONAMED), Coordinación de Investigación en Salud, IMSS
Responsible party
José de Jesús Peralta Romero (Principal investigator, head of clinical department of the Unidad de Investigación Médica en Bioquímica, Unidad Médica de Alta Especialidad "Dr. Bernardo Sepúlveda", Centro Médico Nacional Siglo XXI, IMSS, Mexico City, Instituto Mexicano del Seguro Social) — Principal investigator
First posted
Jul 3, 2024
Start date
Sep 1, 2025
Primary completion
Dec 2028 (estimated)
Completion
Dec 2029 (estimated)
Last update
Oct 30, 2026

Study contacts

José de Jesús Peralta Romero, PhD
principal investigator · Instituto Mexicano del Seguro Social
María Fernanda Pérez Hernández, MsC
study director · Instituto Mexicano del Seguro Social

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion